Latest period
$116B
YoY change
+8.3%
5Y CAGR
+1.1%
Peak year (FY2025)
$118B
Latest annual
$118B
Total Liabilities history chart for Johnson & Johnson (JNJ) from 2016 to 2025
Latest: $118B
Total Liabilities growth chart for Johnson & Johnson (JNJ) from 2016 to 2025
Latest: +8.3%
Total Liabilities history table for Johnson & Johnson (JNJ) from 1985 to 2025
| FY2025 | $118B | +8.3% | +$9.05B | ||
| FY2024 | $109B | +10.0% | +$9.83B | ||
| FY2023 | $98.8B | -10.7% | -$11.8B | ||
| FY2022 | $111B | +2.4% | +$2.58B | ||
| FY2021 | $108B | -3.2% | -$3.62B | ||
| FY2020 | $112B | +13.6% | +$13.4B | ||
| FY2019 | $98.3B | +5.4% | +$5.06B | ||
| FY2018 | $93.2B | -4.1% | -$3.94B | ||
| FY2017 | $97.1B | +37.2% | +$26.4B | ||
| FY2016 | $70.8B | +13.7% | +$8.53B | ||
| FY2015 | $62.3B | +1.5% | +$894M | ||
| FY2014 | $61.4B | +4.7% | +$2.74B | ||
| FY2013 | $58.6B | +3.7% | +$2.11B | ||
| FY2012 | $56.5B | -0.1% | -$43M | ||
| FY2011 | $56.6B | +22.1% | +$10.2B | ||
| FY2010 | $46.3B | +5.1% | +$2.24B | ||
| FY2009 | $44.1B | +4.0% | +$1.69B | ||
| FY2008 | $42.4B | +12.7% | +$4.77B | ||
| FY2007 | $37.6B | +20.5% | +$6.4B | ||
| FY2006 | $31.2B | +55.0% | +$11.1B | ||
| FY2005 | $20.2B | -6.3% | -$1.35B | ||
| FY2004 | $21.5B | +0.5% | +$110M | ||
| FY2003 | $21.4B | +19.8% | +$3.54B | ||
| FY2002 | $17.9B | +25.3% | +$3.6B | ||
| FY2001 | $14.3B | +2.9% | +$405M | ||
| FY2000 | $13.9B | +6.9% | +$900M | ||
| FY1999 | $13B | -2.0% | -$265M | ||
| FY1998 | $13.2B | +45.3% | +$4.12B | ||
| FY1997 | $9.09B | -0.9% | -$80M | ||
| FY1996 | $9.17B | +3.9% | +$346M | ||
| FY1995 | $8.83B | +3.3% | +$282M | ||
| FY1994 | $8.55B | +28.0% | +$1.87B | ||
| FY1993 | $6.67B | -0.6% | -$39M | ||
| FY1992 | $6.71B | +37.4% | +$1.83B | ||
| FY1991 | $4.89B | +6.1% | +$281M | ||
| FY1990 | $4.61B | +22.1% | +$835M | ||
| FY1989 | $3.77B | +4.3% | +$155M | ||
| FY1988 | $3.62B | +18.1% | +$555M | ||
| FY1987 | $3.06B | +0.3% | +$8.5M | ||
| FY1986 | $3.05B | +75.0% | +$1.31B | ||
| FY1985 | $1.74B | — | — |
- FY2025$118B+8.3%
- FY2024$109B+10.0%
- FY2023$98.8B-10.7%
- FY2022$111B+2.4%
- FY2021$108B-3.2%
- FY2020$112B+13.6%
- FY2019$98.3B+5.4%
- FY2018$93.2B-4.1%
- FY2017$97.1B+37.2%
- FY2016$70.8B+13.7%
- FY2015$62.3B+1.5%
- FY2014$61.4B+4.7%
- FY2013$58.6B+3.7%
- FY2012$56.5B-0.1%
- FY2011$56.6B+22.1%
- FY2010$46.3B+5.1%
- FY2009$44.1B+4.0%
- FY2008$42.4B+12.7%
- FY2007$37.6B+20.5%
- FY2006$31.2B+55.0%
- FY2005$20.2B-6.3%
- FY2004$21.5B+0.5%
- FY2003$21.4B+19.8%
- FY2002$17.9B+25.3%
- FY2001$14.3B+2.9%
- FY2000$13.9B+6.9%
- FY1999$13B-2.0%
- FY1998$13.2B+45.3%
- FY1997$9.09B-0.9%
- FY1996$9.17B+3.9%
- FY1995$8.83B+3.3%
- FY1994$8.55B+28.0%
- FY1993$6.67B-0.6%
- FY1992$6.71B+37.4%
- FY1991$4.89B+6.1%
- FY1990$4.61B+22.1%
- FY1989$3.77B+4.3%
- FY1988$3.62B+18.1%
- FY1987$3.06B+0.3%
- FY1986$3.05B+75.0%
- FY1985$1.74B—
Total Liabilities values are taken from Johnson & Johnson's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Liabilities at Johnson & Johnson (JNJ)
According to Johnson & Johnson's latest reported financial statements, the company's latest reported total liabilities is $116B. Total liabilities sum everything the company owes at the end of each reporting period — accounts payable, accrued expenses, debt, lease obligations, and other claims — as filed on the balance sheet. Compare with total assets and total equity for solvency context.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual total liabilities for Johnson & Johnson (JNJ) came in at $118B – grew 8.3% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Johnson & Johnson total liabilities compounded at +1.1% per year, with mixed annual results across the window.
Across the available history, total liabilities reached its high of $118B in 2025 and its low of $1.74B in 1985.
Johnson & Johnson Total Liabilities by Year
Johnson & Johnson Total Liabilities 2025: $118B
2025's total liabilities for Johnson & Johnson came in at $118B, grew 8.3% from 2024. This figure represents the highest annual value in the available history.
Johnson & Johnson Total Liabilities 2024: $109B
Johnson & Johnson posted total liabilities of $109B in 2024, grew 10.0% from 2023.
Johnson & Johnson Total Liabilities 2023: $98.8B
In 2023, Johnson & Johnson reported total liabilities of $98.8B, declined 10.7% below 2022.
Johnson & Johnson Total Liabilities 2022: $111B
Johnson & Johnson total liabilities in 2022 was $111B, edged up 2.4% from 2021.
Johnson & Johnson Total Liabilities 2021: $108B
Johnson & Johnson total liabilities in 2021 was $108B.
See more financial history for Johnson & Johnson (JNJ).
Sector peers by Total Liabilities
Healthcare peers of Johnson & Johnson (JNJ), ranked by their latest total liabilities
| $208B | |
| $137B | |
| $85.9B | |
| $84.2B | |
| $81.9B | |
| $56.8B | |
| $54.9B | |
| $33.9B |
- $137B
- $85.9B
- $84.2B
- $81.9B
- $54.9B
Frequently asked questions
Johnson & Johnson (JNJ) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks1.28% TTM
- Dividend Profile1.97% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History7 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.